Beyond the Surface: The Hidden Struggles of PCOS

Authors

  • Abrar Bashir Malik Department of Pharmacology, CT Institute of Pharmaceutical Sciences, PTU, Jalandhar Punjab, India.
  • Zulfkar Qadrie Senior Resident, Department of Pharmacology, Government Medical College Baramulla, India.
  • Mohd Altaf Dar Department of Pharmacology, CT Institute of Pharmaceutical Sciences, PTU, Jalandhar Punjab, India.

Keywords:

PCOS, fertility, miscarriage, infertility.

Abstract

ABSTRACT

Polycystic Ovary Syndrome (PCOS) presents more than just physical symptoms; beneath the surface lie hidden struggles that profoundly impact those affected. While irregular periods and hormonal imbalances are recognized, the emotional toll is often overlooked. Elevated androgens can trigger mood disturbances, anxiety, and depression, creating a silent battle within. Fertility challenges add another layer of complexity. Conception difficulties, miscarriages, and fertility treatments expose individuals to a rollercoaster of hope and heartache. PCOS also inflicts a psychological burden, eroding self-esteem due to weight gain and societal beauty standards. Healthcare disparities and cultural stigmatization amplify the struggle, hindering proper diagnosis and treatment access. To address these hidden challenges, a holistic approach is imperative. Healthcare providers must acknowledge the emotional aspects, and awareness campaigns should dispel stigma. Empowering support networks can provide solace, while education fosters better self-care. By uncovering and addressing these concealed battles, we pave the way for comprehensive care, improved well-being, and a deeper understanding of the complex reality that PCOS entails.

Keywords: PCOS, fertility, miscarriage, infertility.

Downloads

Download data is not yet available.

Introduction

Introduction: Polycystic Ovary Syndrome (PCOS) is a prevalent and complex endocrine disorder that affects individuals in multifaceted ways, extending far beyond its commonly recognized symptoms. While irregular periods, cystic ovaries, and hormonal imbalances are well-known hallmarks, there exist numerous hidden struggles associated with PCOS that significantly impact physical, emotional, and social well-being [1-5]. This article delves deeper into these less-discussed aspects of PCOS, highlighting the challenges that often go unnoticed or underestimated. By unveiling these hidden struggles, we aim to foster a better understanding of PCOS and advocate for comprehensive care and support for individuals living with this condition [5-10].

The Hormonal Landscape

Polycystic Ovary Syndrome (PCOS) is a multifaceted endocrine disorder that disrupts the delicate hormonal balance within a woman's body. While it is often characterized by its visible symptoms, such as irregular menstrual cycles, cystic ovaries, and hirsutism, the true complexity of PCOS lies within its intricate hormonal landscape. This article delves into the various hormonal aspects of PCOS, shedding light on the mechanisms that contribute to its manifestations and exploring the broader implications for affected individuals [10-15]. At the core of PCOS lies the disruption of hormonal regulation, primarily involving insulin and androgens. Insulin resistance, a key player in PCOS, leads to elevated insulin levels in the bloodstream. This triggers the ovaries to produce excessive amounts of androgens, the male hormones that are normally present in smaller quantities in females [15-17]. The excess androgens contribute to the development of hirsutism (excessive hair growth), acne, and male-pattern baldness. Additionally, these hormonal imbalances can hinder the regular release of eggs during the menstrual cycle, leading to irregular or absent periods, which further exacerbate the complexities of PCOS. The intricate interplay between insulin and androgens creates a feedback loop that perpetuates the hormonal dysregulation. High insulin levels stimulate the ovaries to produce more androgens, while the excess androgens contribute to insulin resistance. This cyclic pattern amplifies the impact of PCOS on both the endocrine and metabolic systems, leading to challenges in managing weight and an increased risk of type 2 diabetes [17-20]. Beyond the physiological implications, the hormonal landscape of PCOS extends its influence to emotional well-being. Research suggests a connection between hormonal imbalances and mood disturbances, such as anxiety and depression. Fluctuations in androgen levels can impact neurotransmitters and receptors in the brain, influencing mood regulation. Moreover, the emotional toll of managing the physical symptoms, fertility struggles, and societal pressures can further compound the psychological impact of PCOS. Fertility struggles within the hormonal landscape of PCOS stem from anovulation, or the lack of regular ovulation. Without ovulation, the release of a mature egg from the ovary does not occur, leading to difficulties in conceiving [20-25]. The hormonal imbalances disrupt the delicate hormonal choreography necessary for ovulation, creating a significant barrier for individuals seeking to start or expand their families. Fertility treatments, such as ovulation-inducing medications or assisted reproductive technologies, often become necessary for those with PCOS who wish to conceive. Management of the hormonal landscape of PCOS requires a multifaceted approach. Lifestyle modifications, such as regular exercise, a balanced diet, and weight management, can help improve insulin sensitivity and hormone levels. Hormonal contraceptives are often prescribed to regulate menstrual cycles and manage androgen-driven symptoms. For individuals seeking fertility, ovulation-inducing medications and assisted reproductive technologies offer hope [25-30]. The hormonal landscape of PCOS is a complex terrain marked by disruptions in insulin regulation and androgen production. Beyond the visible symptoms, the hormonal intricacies impact various aspects of a woman's life, from physical well-being to emotional and psychological health. Navigating this landscape requires a comprehensive approach that addresses both the physiological and emotional dimensions of PCOS. By understanding and addressing the multifaceted hormonal challenges, healthcare providers and individuals alike can work towards managing the complexities of PCOS and improving the overall quality of life for those affected [30-35].

Fertility and Emotional Turmoil

Polycystic Ovary Syndrome (PCOS), a prevalent endocrine disorder, weaves a complex tapestry of challenges that extend beyond its physical manifestations. Among these hidden struggles, fertility issues stand as a poignant and deeply emotional aspect, impacting individuals in profound ways. This article delves into the intricate interplay between PCOS and fertility, unveiling the emotional turmoil that accompanies the pursuit of parenthood for those affected. Fertility, a cornerstone of human existence, takes on a unique significance for individuals with PCOS [35-40]. Anovulation, a hallmark of PCOS, disrupts the regular release of eggs from the ovaries, leading to irregular or absent menstrual cycles. This irregularity poses a significant challenge for conception, as the absence of ovulation hinders the chances of fertilization. As couples embark on the journey of parenthood, the hidden struggles of fertility become increasingly pronounced. The emotional turmoil of fertility struggles often emerges as a silent and solitary battle. Individuals with PCOS grapple with a mixture of hope and heartache, optimism and uncertainty [40-45]. The desire to conceive is intertwined with anxiety, as each cycle carries the anticipation of potential success or disappointment. Fertility treatments, a beacon of hope for many, introduce additional layers of emotional complexity. While assisted reproductive technologies offer possibilities, they also introduce a rollercoaster of emotions as individuals navigate the challenges of medications, procedures, and the unpredictable outcome of each attempt. The emotional impact reverberates through all facets of life. Relationships may be strained as couples cope with the emotional weight of fertility struggles. Intimacy, once a source of connection and joy, can become fraught with pressure and anxiety. The constant emotional cycle of hope and disappointment can create a sense of isolation, as individuals grapple with feelings of inadequacy and guilt, wondering why their bodies are not cooperating with their aspirations. Moreover, societal expectations and cultural norms amplify the emotional turmoil of PCOS-related fertility struggles. Well-intentioned inquiries about family planning can be a source of distress, particularly when faced with the frustration of not being able to fulfill those expectations [45-50]. As individuals are bombarded with images of happy families and social media announcements, the stark contrast with their personal journey can be emotionally taxing. Coping with the emotional turmoil of PCOS-related fertility struggles requires a multidimensional approach. Communication is vital, as open conversations between partners can foster understanding and unity during challenging times. Seeking support from healthcare professionals who specialize in fertility and PCOS can provide both medical guidance and emotional validation. Additionally, connecting with support groups or seeking therapy can offer a safe space for processing emotions and finding solace among those who share similar experiences. The intertwining pathways of fertility and emotional turmoil within the context of PCOS create a complex and deeply personal journey. The pursuit of parenthood for individuals with PCOS is characterized by hope, resilience, and heartache. Acknowledging the emotional impact of fertility struggles is essential for comprehensive care, emphasizing that addressing the hidden struggles beyond the physical symptoms is vital for the well-being of those navigating the intricate landscape of PCOS-related fertility challenges [50-55].

The Psychological Burden

Polycystic Ovary Syndrome (PCOS), a common endocrine disorder, extends its influence beyond the physical realm, casting a shadow over the psychological well-being of those affected. Amid the visible symptoms lies a profound psychological burden that often remains unnoticed or underestimated. This article delves into the intricacies of the psychological challenges posed by PCOS, shedding light on the emotional toll it exacts and exploring strategies for managing and mitigating its impact [55-60]. The psychological burden of PCOS is intimately linked to its hormonal complexities. Hormonal imbalances, driven by elevated androgens and insulin resistance, extend their effects to mood regulation and emotional stability. The fluctuation of hormones can give rise to mood disturbances, including anxiety, depression, and irritability. The emotional turmoil becomes a silent struggle, impacting individuals' daily lives and creating a sense of unpredictability in their emotional responses. Body image and self-esteem emerge as focal points within the psychological landscape of PCOS. The visible manifestations of the disorder, such as hirsutism (excessive hair growth) and weight gain, can profoundly affect how individuals perceive themselves. Society's emphasis on conventional standards of beauty exacerbates the struggle, leading to self-consciousness, comparison, and a heightened vulnerability to negative body image [60-65]. The psychological toll extends beyond physical appearance, infiltrating self-worth and self-acceptance. Intimacy and relationships are not immune to the psychological burden of PCOS. The emotional impact of the disorder can strain intimate connections, as individuals grapple with feelings of inadequacy and self-doubt. Communicating the intricacies of PCOS-related emotional challenges to partners can be challenging, further isolating individuals in their struggle to maintain fulfilling relationships. Societal misconceptions and stigmatization contribute to the psychological burden of PCOS [65-70]. The lack of awareness and understanding surrounding the disorder can lead to judgment and misunderstanding from peers, family members, and even healthcare providers. The constant need to explain and educate can foster a sense of alienation and frustration, magnifying the emotional toll. Addressing the psychological burden of PCOS requires a multi-pronged approach. Healthcare providers play a pivotal role by recognizing and validating the emotional challenges associated with the disorder. Incorporating mental health assessments into PCOS care can help identify and address mood disturbances and provide appropriate support [70-75]. Cognitive-behavioral therapy and other psychotherapeutic interventions offer effective strategies for managing anxiety, depression, and body image concerns. Support networks, both online and offline, provide a platform for individuals to share their experiences, exchange coping strategies, and find solace in a community that understands their journey. Cultivating self-compassion and self-care practices can empower individuals to navigate the psychological landscape of PCOS with resilience and self-assurance. The psychological burden of PCOS is a complex and often overlooked facet of the disorder. Beyond its physical manifestations, PCOS casts a far-reaching shadow over emotional well-being, affecting mood, self-esteem, relationships, and self-identity. Acknowledging and addressing this hidden struggle is paramount for comprehensive PCOS care, emphasizing the need for holistic support that encompasses both the physiological and psychological dimensions of the disorder [75-80].

Navigating Healthcare Disparities

Polycystic Ovary Syndrome (PCOS), a prevalent endocrine disorder, unveils a critical challenge beyond its physiological complexities – the presence of healthcare disparities that disproportionately affect individuals seeking diagnosis, treatment, and support. This article delves into the intricate web of healthcare disparities associated with PCOS, shedding light on the barriers that hinder equitable care and exploring strategies to bridge the gap and ensure that all individuals, regardless of their background, receive the attention and support they deserve [80-85]. Healthcare disparities within the realm of PCOS encompass various dimensions, including access to accurate diagnosis, specialized care, and comprehensive treatment. Socioeconomic factors often play a significant role, as individuals from marginalized communities may face financial constraints that limit their ability to seek medical attention. Lack of insurance coverage, high healthcare costs, and limited access to specialized providers compound the challenge, leaving many individuals with PCOS without adequate care. Cultural perspectives further contribute to healthcare disparities, as certain communities may hold unique beliefs about health and illness. Misunderstandings about PCOS, language barriers, and cultural norms can hinder effective communication between patients and healthcare providers. This disconnect may lead to delayed diagnoses, mismanagement of symptoms, and inadequate education about PCOS [85-90]. The gendered nature of PCOS also introduces disparities. Women's health concerns have historically been marginalized within the medical field, leading to a lack of research, understanding, and resources dedicated to conditions like PCOS. As a result, many healthcare professionals may lack the necessary knowledge to provide accurate diagnosis and appropriate treatment options. To navigate these disparities, a multifaceted approach is imperative. Healthcare providers must engage in culturally competent care, recognizing and respecting the diverse backgrounds of their patients. Offering patient education materials in multiple languages and tailoring communication to address cultural sensitivities can bridge gaps in understanding and empower patients to take an active role in their care. Creating avenues for accessible and affordable care is crucial [90-95]. Community health clinics, support groups, and telehealth services can provide alternatives for individuals facing financial constraints or geographical limitations. Policymakers can play a role by advocating for insurance coverage and reducing out-of-pocket expenses for PCOS-related care. Increasing awareness and education about PCOS within both medical and public spheres is fundamental. By amplifying awareness campaigns and promoting accurate information, we can dismantle misconceptions and empower individuals to seek timely and appropriate care. Additionally, fostering collaborations between researchers, clinicians, and advocacy groups can drive advancements in PCOS diagnosis, treatment, and support. Navigating healthcare disparities of PCOS requires a concerted effort to address the multifaceted barriers that hinder equitable care. By recognizing the intersection of socioeconomic factors, cultural perspectives, and gender bias, we can develop comprehensive strategies to ensure that individuals with PCOS receive the support and resources they need to effectively manage their condition. Bridging the gap in healthcare disparities is a pivotal step toward a future where every individual affected by PCOS can access timely and equitable care, regardless of their background or circumstances [95-100].

Cultural Perspectives and Stigmatization

Polycystic Ovary Syndrome (PCOS), a complex endocrine disorder, is not only characterized by its physiological manifestations but also by the lens through which it is viewed within different cultural contexts. This article delves into the nuanced cultural perspectives surrounding PCOS and the stigmatization that often accompanies it, exploring the ways in which cultural beliefs, traditions, and societal norms contribute to barriers in diagnosis, treatment, and overall well-being. Cultural perspectives regarding health and illness vary widely across different communities [100-110]. For some, PCOS may be considered a taboo topic, associated with shame or misunderstanding. Misconceptions about the disorder's causes and symptoms can lead to delays in seeking medical attention or to reliance on traditional remedies that may not effectively address the underlying hormonal imbalances. Furthermore, certain cultures place a strong emphasis on fertility and motherhood, which can intensify the psychological burden for those with PCOS facing difficulties conceiving. Stigmatization adds another layer of complexity to the experience of individuals with PCOS [110-120]. Societal beauty standards often clash with the visible symptoms of PCOS, such as weight gain and hirsutism (excessive hair growth), leading to feelings of self-consciousness and inadequacy. Stigmatization also surfaces in interactions with healthcare providers, where judgments or lack of understanding can hinder effective communication and treatment. The intersection of cultural perspectives and stigmatization poses significant challenges for individuals with PCOS. Cultural norms can create barriers to open discussions about health concerns, leading to silence and isolation. The fear of being judged or misunderstood may prevent individuals from seeking medical help or support from their communities. Additionally, the emotional toll of internalizing stigmatizing attitudes can impact self-esteem, mental health, and overall well-being. Breaking down these barriers requires a comprehensive approach that respects cultural diversity while challenging stigmatizing beliefs. Education plays a pivotal role, as raising awareness about PCOS within culturally sensitive contexts can dispel myths and misconceptions [120-125]. Culturally tailored educational materials and outreach efforts can empower individuals to recognize the signs of PCOS and seek appropriate care. Open dialogue and community support also play a crucial role in dismantling stigmatization. Support groups that provide a safe space for sharing experiences and fostering understanding can help individuals overcome feelings of isolation. Community leaders, healthcare providers, and policymakers have the opportunity to initiate conversations that challenge stigmatizing narratives and promote acceptance and empathy. Cultural perspectives and stigmatization significantly impact the experience of individuals with PCOS, shaping their understanding of the disorder and influencing their access to care and support. By acknowledging the diverse cultural contexts and addressing stigmatizing attitudes, we can create an environment where individuals with PCOS feel empowered to seek help, engage in informed discussions, and navigate their journey towards well-being with compassion and understanding [125-135].

Empowering Change and Holistic Support

Polycystic Ovary Syndrome (PCOS), a complex endocrine disorder, requires a transformative and holistic approach that extends beyond medical treatments. This article delves into the concept of empowering change and providing comprehensive support for individuals with PCOS, emphasizing the importance of addressing not only the physical symptoms but also the emotional, psychological, and lifestyle dimensions of the condition [135-140]. Empowerment begins with education and awareness. Disseminating accurate information about PCOS is essential to dispel myths, reduce stigma, and empower individuals to make informed decisions about their health. Educational initiatives should encompass various platforms, including community workshops, online resources, and partnerships with healthcare providers. Holistic support involves a multidisciplinary approach. Healthcare providers play a central role in offering comprehensive care that encompasses medical interventions, nutritional guidance, mental health support, and lifestyle management. Collaborative care teams can address the diverse challenges of PCOS, tailoring interventions to each individual's unique needs. Lifestyle modification is a cornerstone of holistic support. Encouraging regular physical activity, balanced nutrition, stress reduction techniques, and sufficient sleep can positively impact hormonal balance and overall well-being [140-145]. Lifestyle changes should be sustainable and adaptable, empowering individuals to take an active role in managing their condition. Mental health and emotional well-being are integral to holistic support. The emotional toll of PCOS, including anxiety, depression, and body image concerns, should be acknowledged and addressed. Mental health professionals can provide coping strategies, counseling, and emotional validation, fostering resilience and self-compassion. Community and peer support play a pivotal role in empowerment. Establishing support groups, both in-person and online, offers individuals a platform to share experiences, exchange advice, and find emotional validation. Connecting with others who understand the challenges of PCOS can create a sense of belonging and reduce feelings of isolation [145-150]. Self-advocacy is a key aspect of empowerment. Encouraging individuals to communicate their needs, preferences, and concerns with healthcare providers fosters a collaborative and patient-centered approach to care. Empowered individuals actively participate in treatment decisions and set achievable goals for their health journey. Moreover, empowering change extends to societal and policy levels. Advocacy efforts can raise awareness about PCOS, influence healthcare policies, and promote research funding. By advocating for increased research into PCOS causes, treatments, and long-term effects, we can drive advancements in understanding and managing the condition. Empowering change and providing holistic support for PCOS requires a collective effort that involves individuals, healthcare professionals, communities, and policymakers. By embracing education, multidisciplinary care, lifestyle modification, mental health support, community engagement, and advocacy, we can create an environment where individuals with PCOS are empowered to take charge of their health, navigate challenges with confidence, and cultivate a sense of well-being that encompasses all dimensions of their lives [150-159].

Conclusion

The hidden struggles of PCOS extend far beyond its surface manifestations. By recognizing and addressing the emotional, psychological, and social challenges that individuals with PCOS face, we can create a more inclusive and compassionate healthcare landscape. Empowering those affected by PCOS with knowledge, support, and holistic care can contribute to better overall well-being and quality of life. As we unveil these hidden struggles, we move closer to a future where individuals with PCOS receive the comprehensive care and understanding they truly deserve.

References

R.J.R.b.o. Azziz, PCOS: a diagnostic challenge, 8(6) (2004) 644-648.

S.F. Witchel, H.J. Teede, A.S.J.P.r. Peña, Curtailing pcos, 87(2) (2020) 353-361.

M.D. Kahsar-Miller, C. Nixon, L.R. Boots, R.C. Go, R.J.F. Azziz, sterility, Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS, 75(1) (2001) 53-58.

R.L. Rosenfield, D.A.J.E.r. Ehrmann, The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited, 37(5) (2016) 467-520.

M. Zehravi, M. Maqbool, I.J.I.j.o.a.m. Ara, health, Polycystic ovary syndrome and infertility: an update, 34(2) (2021) 1-9.

E. Diamanti-Kandarakis, C.D.J.D. Christakou, m.o.p.o. syndrome, Insulin resistance in PCOS, (2009) 35-61.

A.M. Venkatesan, A. Dunaif, A.J.R.p.i.h.r. Corbould, Insulin resistance in polycystic ovary syndrome: progress and paradoxes, 56 (2001) 295-308.

R.S. Legro, V.D. Castracane, R.P.J.O. Kauffman, g. survey, Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls, 59(2) (2004) 141-154.

E. Diamanti-Kandarakis, A.G.J.T.i.m.m. Papavassiliou, Molecular mechanisms of insulin resistance in polycystic ovary syndrome, 12(7) (2006) 324-332.

A. Galluzzo, M.C. Amato, C.J.N. Giordano, Metabolism, C. Diseases, Insulin resistance and polycystic ovary syndrome, 18(7) (2008) 511-518.

K. Polak, A. Czyzyk, T. Simoncini, B.J.J.o.e.i. Meczekalski, New markers of insulin resistance in polycystic ovary syndrome, 40 (2017) 1-8.

M. Mohd, M. Maqbool, M.A. Dar, I.J.J.o.D.D. Mushtaq, Therapeutics, Polycystic ovary syndrome, a modern epidemic: an overview, 9(3) (2019) 641-644.

H. Farshchi, A. Rane, A. Love, R.J.J.o.o. Kennedy, gynaecology, Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management, 27(8) (2007) 762-773.

X. Zhang, Y. Zheng, Y. Guo, Z.J.I.J.o.E. Lai, The effect of low carbohydrate diet on polycystic ovary syndrome: a meta-analysis of randomized controlled trials, 2019 (2019).

J. Frary, K. Bjerre, D. Glintborg, P.J.M.E. Ravn, The effect of dietary carbohydrates in women with polycystic ovary syndrome, 10(10) (2014).

K. Papavasiliou, E.J.N. Papakonstantinou, d. supplements, Nutritional support and dietary interventions for women with polycystic ovary syndrome, (2017) 63-85.

M. Boyd, J.J.T.i.C.N. Ziegler, Polycystic ovary syndrome, fertility, diet, and lifestyle modifications: a review of the current evidence, 34(1) (2019) 14-30.

L.J. Moran, C.B. Lombard, S. Lim, M. Noakes, H.J.J.W.s.h. Teede, Polycystic ovary syndrome and weight management, 6(2) (2010) 271-283.

J. Kataoka, E.C. Tassone, M. Misso, A.E. Joham, E. Stener-Victorin, H. Teede, L.J.J.N. Moran, Weight management interventions in women with and without PCOS: a systematic review, 9(9) (2017) 996.

B. Ozgen Saydam, B.O.J.E.r.o.e. Yildiz, metabolism, Weight management strategies for patients with PCOS: current perspectives, 16(2) (2021) 49-62.

M. Zehravi, M. Maqbool, I.J.I.j.o.a.m. Ara, health, Polycystic ovary syndrome and reproductive health of women: a curious association, 33(6) (2021) 333-337.

P. Moghetti, F.J.J.o.e.i. Tosi, Insulin resistance and PCOS: chicken or egg?, 44 (2021) 233-244.

H. Zhao, J. Zhang, X. Cheng, X. Nie, B.J.J.o.O.R. He, Insulin resistance in polycystic ovary syndrome across various tissues: An updated review of pathogenesis, evaluation, and treatment, 16(1) (2023) 9.

M. Khmil, S. Khmil, M.J.O.A.M.J.o.M.S. Marushchak, Hormone imbalance in women with infertility caused by polycystic ovary syndrome: is there a connection with body mass index?, 8(B) (2020) 731-737.

R. Shahid, Mahnoor, K.A. Awan, M.J. Iqbal, H. Munir, I.J.J.o.F.B. Saeed, Diet and lifestyle modifications for effective management of polycystic ovarian syndrome (PCOS), 46(7) (2022) e14117.

E. Rudnicka, K. Suchta, M. Grymowicz, A. Calik-Ksepka, K. Smolarczyk, A.M. Duszewska, R. Smolarczyk, B.J.I.j.o.m.s. Meczekalski, Chronic low grade inflammation in pathogenesis of PCOS, 22(7) (2021) 3789.

M. Rostamtabar, S. Esmaeilzadeh, M. Tourani, A. Rahmani, M. Baee, F. Shirafkan, K. Saleki, S.S. Mirzababayi, S. Ebrahimpour, H.R.J.J.o.c.p. Nouri, Pathophysiological roles of chronic low‐grade inflammation mediators in polycystic ovary syndrome, 236(2) (2021) 824-838.

D. Liu, Y. Huang, C. Huang, S. Yang, X. Wei, P. Zhang, D. Guo, J. Lin, B. Xu, C.J.N.E.J.o.M. Li, Calorie restriction with or without time-restricted eating in weight loss, 386(16) (2022) 1495-1504.

J.Y.J.J.o.o. Kim, m. syndrome, Optimal diet strategies for weight loss and weight loss maintenance, 30(1) (2021) 20.

R.J.N. Freire, Scientific evidence of diets for weight loss: Different macronutrient composition, intermittent fasting, and popular diets, 69 (2020) 110549.

P.J.O. Piaggi, Metabolic determinants of weight gain in humans, 27(5) (2019) 691-699.

J. Moon, G.J.J.o.o. Koh, m. syndrome, Clinical evidence and mechanisms of high-protein diet-induced weight loss, 29(3) (2020) 166.

A.W. Lin, D. Siscovick, B. Sternfeld, P. Schreiner, C.E. Lewis, E.T. Wang, S.S. Merkin, M. Wellons, L. Steffen, R.J.B.P.H. Calderon-Margalit, Associations of diet, physical activity and polycystic ovary syndrome in the Coronary Artery Risk Development in Young Adults Women’s Study, 21 (2021) 1-10.

S. Cowan, S. Lim, C. Alycia, S. Pirotta, R. Thomson, M. Gibson-Helm, R. Blackmore, N. Naderpoor, C. Bennett, C.J.B.E.D. Ee, Lifestyle management in polycystic ovary syndrome–beyond diet and physical activity, 23(1) (2023) 14.

X. Che, Z. Chen, M. Liu, Z.J.A.o.N. Mo, Metabolism, Dietary interventions: a promising treatment for polycystic ovary syndrome, 77(6) (2021) 313-323.

A. Ullah, M.-J. Wang, J.-P. Yang, E.A. Adu-Gyamfi, A. Czika, S.K. Sah, Q. Feng, Y.-X.J.R.B.O. Wang, Ovarian inflammatory mRNA profiles of a dehydroepiandrosterone plus high-fat diet-induced polycystic ovary syndrome mouse model, 44(5) (2022) 791-802.

R.I. Cincione, F. Losavio, F. Ciolli, A. Valenzano, G. Cibelli, G. Messina, R.J.I.j.o.e.r. Polito, p. health, Effects of mixed of a ketogenic diet in overweight and obese women with polycystic ovary syndrome, 18(23) (2021) 12490.

M. Maqbool, I. Ara, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, The Story of Polycystic Ovarian Syndrome: A Challenging Disorder with Numerous Consequences for Females of Reproductive Age, (2022) 19-31.

S. Mei, J. Ding, K. Wang, Z. Ni, J.J.F.i.n. Yu, Mediterranean diet combined with a low-carbohydrate dietary pattern in the treatment of overweight polycystic ovary syndrome patients, 9 (2022) 876620.

A. Nadjarzadeh, A. Ghadiri-Anari, N. Ramezani-Jolfaie, M. Mohammadi, A. Salehi-Abargouei, S.M. Namayande, H. Mozaffari-Khosravi, E.J.C.T.i.M. Hosseini-Marnani, Effect of hypocaloric high-protein, low-carbohydrate diet supplemented with fennel on androgenic and anthropometric indices in overweight and obese women with polycystic ovary syndrome: A randomized placebo-controlled trial, 56 (2021) 102633.

J.M. Aly, A.H.J.C.o. Decherney, gynecology, Lifestyle modifications in PCOS, 64(1) (2021) 83-89.

L. Barrea, A. Arnone, G. Annunziata, G. Muscogiuri, D. Laudisio, C. Salzano, G. Pugliese, A. Colao, S.J.N. Savastano, Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS), 11(10) (2019) 2278.

M.E. Çıtar Dazıroğlu, N.J.C.N.R. Acar Tek, The Effect on Inflammation of Adherence to the Mediterranean Diet in Polycystic Ovary Syndrome, 12(1) (2023) 191-202.

Z.M. Younossi, K.E. Corey, J.K.J.G. Lim, AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review, 160(3) (2021) 912-918.

A. Bruci, D. Tuccinardi, R. Tozzi, A. Balena, S. Santucci, R. Frontani, S. Mariani, S. Basciani, G. Spera, L.J.N. Gnessi, Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure, 12(2) (2020) 333.

A.A. Weaver, D.K. Houston, S.A. Shapses, M.F. Lyles, R.M. Henderson, D.P. Beavers, A.C. Baker, K.M.J.T.A.J.o.C.N. Beavers, Effect of a hypocaloric, nutritionally complete, higher-protein meal plan on bone density and quality in older adults with obesity: a randomized trial, 109(2) (2019) 478-486.

E.A. Hu, V. Nguyen, J. Langheier, D.J.J.o.m.I.r. Shurney, Weight reduction through a digital nutrition and food purchasing platform among users with obesity: longitudinal study, 22(9) (2020) e19634.

C.T. Tay, R. Garrad, A. Mousa, M. Bahri, A. Joham, H.J.J.o.E. Teede, Polycystic ovary syndrome (PCOS): international collaboration to translate evidence and guide future research, 257(3) (2023).

C.T. Tay, R. Garad, A. Mousa, M.B. Khomami, A. Joham, H.J.T.J.o.E. Teede, PCOS: international collaboration to translate evidence and guide future research, (2023) JOE-22.

R.M. Garad, H.J.J.C.O.i.E. Teede, M. Research, Polycystic ovary syndrome: improving policies, awareness, and clinical care, 12 (2020) 112-118.

T. Copp, D.M. Muscat, J. Hersch, K.J. McCaffery, J. Doust, A. Dokras, B.W. Mol, J.J.P.e. Jansen, counseling, The challenges with managing polycystic ovary syndrome: a qualitative study of women’s and clinicians’ experiences, 105(3) (2022) 719-725.

D. Achipa, J. Nteziyaremye, Polycystic Ovarian Syndrome Diagnosis in a Patient Undergoing Treatment for Bipolar Affective Disorder at Mbale Regional Referral Hospital, Uganda, (2020).

C.T. Tay, A.E. Joham, L.J. Moran, H.J.C.O.i.E. Teede, Diabetes, Obesity, Better care for women with polycystic ovary syndrome–a proposal for an international evidence based best practice framework to improve care, 29(6) (2022) 514-520.

P. Luo, J. Li, P. Li, G. Wang, W. Li, Z. Song, X. Sun, Z. Fu, H. Zhou, X.J.F.i.E. Yi, A bibliometric and visual analysis of obesity and polycystic ovary syndrome from 2012 to 2022, 13 (2022) 1011105.

S. Aboeldalyl, C. James, E. Seyam, E.M. Ibrahim, H.E.-D. Shawki, S.J.I.j.o.m.s. Amer, The role of chronic inflammation in polycystic ovarian syndrome—a systematic review and meta-analysis, 22(5) (2021) 2734.

S.A. Dabravolski, N.G. Nikiforov, A.H. Eid, L.V. Nedosugova, A.V. Starodubova, T.V. Popkova, E.E. Bezsonov, A.N.J.I.j.o.m.s. Orekhov, Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome, 22(8) (2021) 3923.

A. Mancini, C. Bruno, E. Vergani, C. d’Abate, E. Giacchi, A.J.I.J.o.M.S. Silvestrini, Oxidative stress and low-grade inflammation in polycystic ovary syndrome: controversies and new insights, 22(4) (2021) 1667.

M. Maqbool, M. Khan, M. Mohammad, M.A. Adesina, G.J.J.o.A.P.S. Fekadu, Research, Awareness about reproductive health in adolescents and youth: a review, (2019) 1-5.

M. Popovic, G. Sartorius, M. Christ-Crain, Chronic low-grade inflammation in polycystic ovary syndrome: is there a (patho)-physiological role for interleukin-1?, Seminars in immunopathology, Springer, 2019, pp. 447-459.

S.F. de Medeiros, M.A.S. de Medeiros, B.B. Barbosa, A.K.L.W. Yamamoto, M.M.W.J.J.o.O. Yamamoto, G. Research, The connection of alpha‐1 acid glycoprotein inflammatory marker with anthropometric, hormonal, and metabolic characteristic of women with polycystic ovary syndrome, 47(10) (2021) 3571-3582.

Y.D. Prabhu, A. Borthakur, A. Subeka, B. Vellingiri, A.V.J.J.o.R.I. Gopalakrishnan, Increased pro-inflammatory cytokines in ovary and effect of γ-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model, 146 (2021) 103345.

Q. Zhang, R. Ye, Y.-Y. Zhang, C.-C. Fan, J. Wang, S. Wang, S. Chen, X.J.F.i.E. Liu, Brown adipose tissue and novel management strategies for polycystic ovary syndrome therapy, 13 (2022) 847249.

J.V. Kolhe, A.S. Chhipa, S. Butani, V. Chavda, S.S.J.R.S. Patel, PCOS and depression: Common links and potential targets, (2021) 1-18.

T.O.J.B.b.r. Tobore, Towards a comprehensive theory of obesity and a healthy diet: The causal role of oxidative stress in food addiction and obesity, 384 (2020) 112560.

H. Yaribeygi, F.R. Farrokhi, A.E. Butler, A.J.J.o.c.p. Sahebkar, Insulin resistance: Review of the underlying molecular mechanisms, 234(6) (2019) 8152-8161.

A.R.J.T.J.o.c.i. Saltiel, Insulin signaling in health and disease, 131(1) (2021).

M.A. Sanchez-Garrido, M.J.M.m. Tena-Sempere, Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies, 35 (2020) 100937.

S.J.C.O.i.E. Franks, M. Research, Androgen production and action in the ovary, 18 (2021) 48-53.

K.M. Brennan, L.L. Kroener, G.D. Chazenbalk, D.A.J.O. Dumesic, g. survey, Polycystic ovary syndrome: impact of lipotoxicity on metabolic and reproductive health, 74(4) (2019) 223.

C. Haudum, L. Lindheim, A. Ascani, C. Trummer, A. Horvath, J. Münzker, B.J.N. Obermayer-Pietsch, Impact of short-term isoflavone intervention in polycystic ovary syndrome (PCOS) patients on microbiota composition and metagenomics, 12(6) (2020) 1622.

M. Shilo, A. Mayo, U.J.F.i.E. Alon, A Mechanism for Ovulation Number Control, 13 (2022) 816967.

I. Chudzicka-Strugała, I. Gołębiewska, B. Banaszewska, G. Brudecki, B.J.N. Zwoździak, The Role of Individually Selected Diets in Obese Women with PCOS—A Review, 14(21) (2022) 4555.

L. Barrea, E. Frias-Toral, L. Verde, F. Ceriani, G. Cucalón, E. Garcia-Velasquez, D. Moretti, S. Savastano, A. Colao, G.J.M.O. Muscogiuri, PCOS and nutritional approaches: Differences between lean and obese phenotype, 12 (2021) 100123.

D. Szukiewicz, S. Trojanowski, A. Kociszewska, G.J.I.J.o.M.S. Szewczyk, Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)—Searching for Epigenetic Factors, 23(23) (2022) 14663.

F. Komal, M.K. Khan, M. Imran, M.H. Ahmad, H. Anwar, U.A. Ashfaq, N. Ahmad, A. Masroor, R.S. Ahmad, M.J.J.o.T.M. Nadeem, Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model, 18 (2020) 1-11.

Y. Xia, Y. Wang, M. Cui, D.J.A.o.p.m. Su, Efficacy of omega-3 fatty acid supplementation on cardiovascular risk factors in patients with polycystic ovary syndrome: a systematic review and meta-analysis, 2021, pp. 6425-6437.

M. Salek, C.C. Clark, M. Taghizadeh, S.J.E.j. Jafarnejad, N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications, 18 (2019) 558.

L. Lu, X. Li, L. Lv, Y. Xu, B. Wu, C.J.F.i.N. Huang, Associations between omega-3 fatty acids and insulin resistance and body composition in women with polycystic ovary syndrome, 9 (2022) 1016943.

M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Patterns of Drug Use in Geriatric Patients at a Tertiary Care Teaching Hospital in Jammu and Kashmir, (2023) 182-186.

M. Szczuko, J. Kikut, U. Szczuko, I. Szydłowska, J. Nawrocka-Rutkowska, M. Ziętek, D. Verbanac, L.J.N. Saso, Nutrition strategy and life style in polycystic ovary syndrome—Narrative review, 13(7) (2021) 2452.

C. Ee, S. Pirotta, A. Mousa, L. Moran, S.J.B.e.d. Lim, Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success, 21(1) (2021) 1-12.

K. Herawati, D.J.E.c. Gayatri, The correlation between sleep quality and levels of stress among students in Universitas Indonesia, 29 (2019) 357-361.

P.-Y. Wang, K.-L. Chen, S.-Y. Yang, P.-H.J.P.o. Lin, Relationship of sleep quality, smartphone dependence, and health-related behaviors in female junior college students, 14(4) (2019) e0214769.

T. Sathyapalan, J.P. Hobkirk, Z. Javed, S. Carroll, A.-M. Coady, P. Pemberton, A. Smith, K. Cianflone, S.L.J.F.i.E. Atkin, The effect of atorvastatin (and subsequent metformin) on adipose tissue acylation-stimulatory-protein concentration and inflammatory biomarkers in overweight/obese women with polycystic ovary syndrome, 10 (2019) 394.

K.D. Hall, I.S. Farooqi, J.M. Friedman, S. Klein, R.J. Loos, D.J. Mangelsdorf, S. O'Rahilly, E. Ravussin, L.M. Redman, D.H.J.T.A.J.o.C.N. Ryan, The energy balance model of obesity: beyond calories in, calories out, 115(5) (2022) 1243-1254.

Q. Xia, W. Wang, Z. Liu, J. Xiao, C. Qiao, Y. Zhao, B. Li, Y. Liu, Y. Peng, X.J.E.J.o.P. Yang, New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties, (2022) 175433.

Y. Zhai, Y.J.J.o.R.I. Pang, Systemic and ovarian inflammation in women with polycystic ovary syndrome, 151 (2022) 103628.

D. Armanini, M. Boscaro, L. Bordin, C.J.I.j.o.m.s. Sabbadin, Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism, 23(8) (2022) 4110.

Y. Zhang, Y. Ran, L. Kong, L. Geng, H. Huang, H. Zhang, J. Hu, H. Qi, Y.J.J.o.O.R. Chen, Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism, 14 (2021) 1-10.

L. Della Corte, V. Foreste, F. Barra, C. Gustavino, F. Alessandri, M.G. Centurioni, S. Ferrero, G. Bifulco, P.J.E.O.o.I.D. Giampaolino, Current and experimental drug therapy for the treatment of polycystic ovarian syndrome, 29(8) (2020) 819-830.

K. Lejman-Larysz, A. Golara, M. Baranowska, M. Kozłowski, P. Guzik, I. Szydłowska, J. Nawrocka-Rutkowska, E. Sowińska-Przepiera, A. Cymbaluk-Płoska, A.J.N. Brodowska, Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome, 15(13) (2023) 2952.

M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Metformin and Other Sulfonylureas for Glycemic Control in Type 2 Diabetic Patients at a Tertiary Care Hospital in Jammu & Kashmir, (2023) 197-201.

A. Balkrishna, M. Rana, S. Mishra, D. Srivastava, R. Bhardwaj, S. Singh, S.K. Rajput, V.J.E.-B.C. Arya, A. Medicine, Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management, 2023 (2023).

Z. Guleken, H. Bulut, B. Bulut, W. Paja, B. Orzechowska, M. Parlinska-Wojtan, J.J.S.A.P.A.M. Depciuch, B. Spectroscopy, Identification of polycystic ovary syndrome from blood serum using hormone levels via Raman spectroscopy and multivariate analysis, 273 (2022) 121029.

R. Azziz, K. Kintziger, R. Li, J. Laven, L. Morin-Papunen, S.S. Merkin, H. Teede, B.O.J.H.r. Yildiz, Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource, 34(11) (2019) 2254-2265.

P. Kempegowda, E. Melson, K.N. Manolopoulos, W. Arlt, M.W.J.T.a.i.e. O’Reilly, metabolism, Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome, 11 (2020) 2042018820934319.

V. De Oliveira, J. Schaefer, B. Abu-Rafea, G.A. Vilos, A.G. Vilos, M. Bhattacharya, S. Radovick, A.V.J.M.h.r. Babwah, Uterine aquaporin expression is dynamically regulated by estradiol and progesterone and ovarian stimulation disrupts embryo implantation without affecting luminal closure, 26(3) (2020) 154-166.

J.A. MacLean, K.J.C. Hayashi, Progesterone actions and resistance in gynecological disorders, 11(4) (2022) 647.

M. Régnier, M. Van Hul, C. Knauf, P.D.J.J.o.E. Cani, Gut microbiome, endocrine control of gut barrier function and metabolic diseases, 248(2) (2021) R67-R82.

F.M. Gribble, F.J.N.R.E. Reimann, Function and mechanisms of enteroendocrine cells and gut hormones in metabolism, 15(4) (2019) 226-237.

I. Domínguez-López, M. Yago-Aragón, A. Salas-Huetos, A. Tresserra-Rimbau, S.J.N. Hurtado-Barroso, Effects of dietary phytoestrogens on hormones throughout a human lifespan: A review, 12(8) (2020) 2456.

M. Bahmani, S. Shokri, Z.N. Akhtar, S. Abbaszadeh, A.J.J.a.r. Manouchehri, The effect of pomegranate seed oil on human health, especially epidemiology of polycystic ovary syndrome; a systematic review, 26(4) (2022) 631.

R. Gharaei, F. Mahdavinezhad, E. Samadian, J. Asadi, Z. Ashrafnezhad, L. Kashani, F.J.J.o.a.r. Amidi, genetics, Antioxidant supplementations ameliorate PCOS complications: a review of RCTs and insights into the underlying mechanisms, (2021) 1-15.

E. Rudnicka, A.M. Duszewska, M. Kucharski, P. Tyczyński, R.J.R. Smolarczyk, Oxidative Stress and Reproductive Function: Oxidative stress in polycystic ovary syndrome, 164(6) (2022) F145-F154.

G. Eslamian, A.J.J.o.r. Hekmatdoost, infertility, Nutrient patterns and risk of polycystic ovary syndrome, 20(3) (2019) 161.

A. Hestiantoro, B.P.K. Astuti, E.O. Joyo, R.R. Febri, V. Silvana, R.J.J.o.t.T.G.G.A. Muharam, Vitamin B 3 (niacin), B 6, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome, 23(3) (2022) 130-136.

Y. Mu, D. Cheng, T.-l. Yin, J.J.R.S. Yang, Vitamin D and polycystic ovary syndrome: a narrative review, 28 (2021) 2110-2117.

E.A. Sulaiman, S. Dhiaa, M.M.J.M. Merkhan, Overview of vitamin D role in polycystic ovarian syndrome, 91(1) (2022) 37-43.

J. Yin, X. Hong, J. Ma, Y. Bu, R.J.F.i.e. Liu, Serum trace elements in patients with polycystic ovary syndrome: a systematic review and meta-analysis, 11 (2020) 572384.

J. Aaseth, S. Ellefsen, U. Alehagen, T.M. Sundfør, J.J.B. Alexander, Pharmacotherapy, Diets and drugs for weight loss and health in obesity–An update, 140 (2021) 111789.

A.R. Kansra, S. Lakkunarajah, M.S.J.F.i.p. Jay, Childhood and adolescent obesity: A review, 8 (2021) 866.

I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Reproductive Health of Women: implications and attributes, (2022) 8-18.

E.K. Farhat, E.K. Sher, A. Džidić-Krivić, I. Banjari, F.J.T.J.o.N.B. Sher, Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment, (2023) 109368.

B. Aftab, M. Imran, S.I.J.J.o.F. Shahrukh, N. Research, Effect of Phytoestrogens in the Treatment of Polycystic Ovary Syndrome in Rat Model, 10(7) (2022) 518-525.

B. Banaszewska, L. Pawelczyk, R.J.R.b. Spaczynski, Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome, 19(4) (2019) 309-315.

J.A. Lentscher, B. Slocum, S.J.C.o. Torrealday, gynecology, Polycystic ovarian syndrome and fertility, 64(1) (2021) 65-75.

V. Calcaterra, E. Verduci, H. Cena, V.C. Magenes, C.F. Todisco, E. Tenuta, C. Gregorio, R. De Giuseppe, A. Bosetti, E.J.N. Di Profio, Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility, 13(6) (2021) 1848.

M.F. Costello, M.L. Misso, A. Balen, J. Boyle, L. Devoto, R.M. Garad, R. Hart, L. Johnson, C. Jordan, R.S.J.A. Legro, N.Z.J.o. Obstetrics, Gynaecology, A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome, 59(6) (2019) 867-873.

M. Li, X. Ruan, A.O.J.G.H.J. Mueck, Management strategy of infertility in polycystic ovary syndrome, 6(2) (2022) 70-74.

J. Collée, M. Mawet, L. Tebache, M. Nisolle, G.J.G.E. Brichant, Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments, 37(10) (2021) 869-874.

Y. Shang, H. Zhou, R. He, W.J.F.i.E. Lu, Dietary modification for reproductive health in women with polycystic ovary syndrome: a systematic review and meta-analysis, 12 (2021) 735954.

N. Saadati, F. Haidari, M. Barati, R. Nikbakht, G. Mirmomeni, F.J.H. Rahim, The effect of low glycemic index diet on the reproductive and clinical profile in women with polycystic ovarian syndrome: A systematic review and meta-analysis, 7(11) (2021).

G. Li, D. Zhao, Q. Wang, M. Zhou, L. Kong, M. Fang, P.J.J.o.P.R. Li, Infertility-related stress and quality of life among infertile women with polycystic ovary syndrome: Does body mass index matter?, 158 (2022) 110908.

J.M. Hazlehurst, P. Singh, G. Bhogal, S. Broughton, A.A.J.C.e. Tahrani, How to manage weight loss in women with obesity and PCOS seeking fertility?, 97(2) (2022) 208-216.

I. Ara, M. Maqbool, M.J.O.H. Zehravi, Psychic consequences of infertility on couples: A short commentary, 3(1) (2022) 114-119.

M.A.d. Castro, M.d.M. Fontanelli, C.A. Nogueira-de-Almeida, M.J.N. Fisberg, Food insecurity reduces the chance of following a nutrient-dense dietary pattern by Brazilian adults: insights from a nationwide cross-sectional survey, 14(10) (2022) 2126.

B.M. Perzia, J.L. Dunaief, D.M.J.B.C.R.C. Dunaief, Chronic migraine reversal and prevention with the LIFE diet: A nutrient dense whole food plant-based diet (WFPBD), 14(12) (2021) e243987.

A.J.F.i.N. Melse-Boonstra, Bioavailability of micronutrients from nutrient-dense whole foods: zooming in on dairy, vegetables, and fruits, 7 (2020) 101.

J.A.J.C.O.i.O. Grieger, Gynecology, Preconception diet, fertility, and later health in pregnancy, 32(3) (2020) 227-232.

M. Bahri Khomami, H.J. Teede, A.E. Joham, L.J. Moran, T.T. Piltonen, J.A.J.C.E. Boyle, Clinical management of pregnancy in women with polycystic ovary syndrome: An expert opinion, 97(2) (2022) 227-236.

K. Deepak Kumar, R. Huntriss, E. Green, S. Bora, C.J.J.o.H.N. Pettitt, Dietetics, Development of a nutrition screening tool to identify need for dietetic intervention in female infertility, 36(1) (2023) 154-168.

Z. Zhang, C. Shi, Z.J.N. Wang, Therapeutic Effects and Molecular Mechanism of Chlorogenic Acid on Polycystic Ovarian Syndrome: Role of HIF-1alpha, 15(13) (2023) 2833.

M. Zehravi, M. Maqbool, I.J.O.H. Ara, Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review, 3(1) (2022) 60-65.

M. Zafar, K. Mills, J. Zheng, M. Peng, X. Ye, L.J.O.R. Chen, Low glycaemic index diets as an intervention for obesity: a systematic review and meta‐analysis, 20(2) (2019) 290-315.

J.Z. Goldenberg, A. Day, G.D. Brinkworth, J. Sato, S. Yamada, T. Jönsson, J. Beardsley, J.A. Johnson, L. Thabane, B.C.J.b. Johnston, Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data, 372 (2021).

K. Rees, A. Takeda, N. Martin, L. Ellis, D. Wijesekara, A. Vepa, A. Das, L. Hartley, S.J.G.h. Stranges, Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease: A Cochrane review, 15(1) (2020).

R.B. Singh, J. Fedacko, G. Fatima, A. Magomedova, S. Watanabe, G.J.N. Elkilany, Why and how the Indo-Mediterranean diet may be superior to other diets: the role of antioxidants in the diet, 14(4) (2022) 898.

N. Parletta, D. Zarnowiecki, J. Cho, A. Wilson, S. Bogomolova, A. Villani, C. Itsiopoulos, T. Niyonsenga, S. Blunden, B.J.N.n. Meyer, A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: A randomized controlled trial (HELFIMED), 22(7) (2019) 474-487.

A. Nani, B. Murtaza, A. Sayed Khan, N.A. Khan, A.J.M. Hichami, Antioxidant and anti-inflammatory potential of polyphenols contained in Mediterranean diet in obesity: Molecular mechanisms, 26(4) (2021) 985.

E. Wawrzyniak-Gramacka, N. Hertmanowska, A. Tylutka, B. Morawin, E. Wacka, M. Gutowicz, A.J.N. Zembron-Lacny, The association of anti-inflammatory diet ingredients and lifestyle exercise with inflammaging, 13(11) (2021) 3696.

V. Rodriguez Paris, S.M. Solon-Biet, A.M. Senior, M.C. Edwards, R. Desai, N. Tedla, M.J. Cox, W.L. Ledger, R.B. Gilchrist, S.J.J.N.c. Simpson, Defining the impact of dietary macronutrient balance on PCOS traits, 11(1) (2020) 5262.

K. Gayathri, V. Supriya, N.J.I.J.o.N. Palaniappan, Pharmacology, Neurological Diseases, Nutritional Composition and Sensory Evaluation of Phytoestrogen-Rich Supplement for Women with PCOS, 11(4) (2021) 303-308.

S. Cienfuegos, S. Corapi, K. Gabel, M. Ezpeleta, F. Kalam, S. Lin, V. Pavlou, K.A.J.N. Varady, Effect of intermittent fasting on reproductive hormone levels in females and males: a review of human trials, 14(11) (2022) 2343.

M. Xenou, K.J.M. Gourounti, Dietary patterns and polycystic ovary syndrome: a systematic review, 16(3) (2021) 516.

C. Kite, I.M. Lahart, I. Afzal, D.R. Broom, H. Randeva, I. Kyrou, J.E.J.S.r. Brown, Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis, 8 (2019) 1-28.

E. Frias-Toral, E. Garcia-Velasquez, M. de Los Angeles Carignano, D. Rodriguez-Veintimilla, I. Alvarado-Aguilera, N.J.M.E. Bautista-Litardo, Polycystic ovary syndrome and obesity: clinical aspects and nutritional management, 47(2) (2021) 215-241.

L. Barrea, L. Verde, E. Camajani, S. Cernea, E. Frias-Toral, D. Lamabadusuriya, F. Ceriani, S. Savastano, A. Colao, G.J.C.N.R. Muscogiuri, Ketogenic diet as medical prescription in women with polycystic ovary syndrome (PCOS), 12(1) (2023) 56-64.

G. Muscogiuri, M. El Ghoch, A. Colao, M. Hassapidou, V. Yumuk, L.J.O.f. Busetto, European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis, 14(2) (2021) 222-245.

M. Mizgier, R. Watrowski, J. Opydo-Szymaczek, E. Jodłowska-Siewert, G. Lombardi, W. Kędzia, G.J.N. Jarząbek-Bielecka, Association of Macronutrients Composition, Physical Activity and Serum Androgen Concentration in Young Women with Polycystic Ovary Syndrome, 14(1) (2021) 73.

R. Kaur, R. Kumar, M.J.E. Gupta, Predicting risk of obesity and meal planning to reduce the obese in adulthood using artificial intelligence, 78(3) (2022) 458-469.

C.C. Douglas, R. Jones, R. Green, K. Brown, G. Yount, R.J.A.J.o.H.E. Williams, University students with PCOS demonstrate limited nutrition knowledge, 52(2) (2021) 80-91.

T.A.J.T.P. Chakravorty, Understanding Polycystic Ovary Syndrome (PCOS):: Symptoms, Diagnosis, Treatment and Future Directions, 8(2) (2023) 1-8.

T.M. Barber, S. Franks, Developmental origins and genetic basis of polycystic ovary syndrome, Human Reproductive and Prenatal Genetics, Elsevier2023, pp. 505-530.

E. Bagatin, M.A.D.d. Rocha, T.H.P. Freitas, C.S.J.E.R.o.C.P. Costa, Treatment challenges in adult female acne and future directions, 14(6) (2021) 687-701.

S.J.I.j.o.w.s.h. Pramodh, Exploration of lifestyle choices, reproductive health knowledge, and polycystic ovary syndrome (Pcos) awareness among female emirati university students, (2020) 927-938.

X. Yin, Y. Ji, C.L.W. Chan, C.H.Y.J.A.o.W.s.M.H. Chan, The mental health of women with polycystic ovary syndrome: a systematic review and meta-analysis, 24 (2021) 11-27.

S. Wei, Y.-Y. Tang, F. Wang, Y. Wang, X.J.F.i.P. Geng, Neural circuits and neuroendocrine mechanisms of depression and premenstrual dysphoric disorder: towards precise targets for translational medicine and drug development, volume II, 14 (2023) 1216689.

S. Shabbir, E. Khurram, V.S. Moorthi, Y.T.H. Eissa, M.A. Kamal, A.E.J.J.o.T.M. Butler, The interplay between androgens and the immune response in polycystic ovary syndrome, 21(1) (2023) 1-26.

M. Ntumy, E. Maya, D. Lizneva, R. Adanu, R.J.G.E. Azziz, The pressing need for standardization in epidemiologic studies of PCOS across the globe, Taylor & Francis, 2019, pp. 1-3.

Downloads

Published

2023-09-30

How to Cite

Bashir Malik, A., Qadrie, Z., & Altaf Dar, M. (2023). Beyond the Surface: The Hidden Struggles of PCOS. International Journal of Current Research in Physiology and Pharmacology, 7(S2), 10–23. Retrieved from https://sumathipublications.com/index.php/ijcrpp/article/view/475

Issue

Section

Review Articles

Most read articles by the same author(s)

1 2 > >>